Insmed (INSM): Assessing Valuation After a Strong Year of Share Price Gains [Yahoo! Finance]
Is It Too Late to Consider Insmed After a 179% Surge and DCF Upside? [Yahoo! Finance]
Insmed (NASDAQ:INSM) had its price target raised by analysts at TD Cowen from $231.00 to $269.00. They now have a "buy" rating on the stock.
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks [Yahoo! Finance]
Questex's Chief Medical Officer Summit 360° Announces 2026 Agenda and Keynotes [Yahoo! Finance]